Kadimastem Receives US Patent for Its Cell Selection & Enrichment Technology Used to Develop IsletRx
Not compatible with Internet Explorer
Not compatible with Internet Explorer
Not compatible with Internet Explorer




- May 15
- 3 min
Kadimastem Granted European Patent for Its IsletRx Treatment for Diabetes


- May 9
- 5 min
Kadimastem and iTolerance Sign Agreement and Receive US$1 Million from BIRD Foundation


- Mar 19
- 4 min
Kadimastem Earns FDA IND Approval For its US Phase IIa Clinical Trial with AstroRx® to Treat ALS


- Feb 19
- 5 min
Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx® for ALS


- Feb 15
- 4 min
Kadimastem's Clinical Trial in ALS Patients was Publicized in the Journal of Translational Medicine


- Feb 5
- 4 min
Awarded Patent in Australia for its AstroRx® Technology for the Treatment of ALS and Drug Screening


- Jan 9
- 3 min
Kadimastem Announces it raised appx 7.5 million NIS by rights offering


- Dec 20, 2022
- 5 min
Kadimastem and iTolerance’s Proposed Collaboration With Receipt of US $1 Million BIRD Grant

- Sep 28, 2022
- 4 min
Kadimastem Receives Approval of Patent registration Used to Develop IsletRx for Diabetes


- Aug 9, 2022
- 4 min
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment


- Jun 8, 2022
- 4 min
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement


- May 30, 2022
- 3 min
Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening


- May 18, 2022
- 4 min
Kadimastem Expands R&D Program to Include Multiple Sclerosis


- Mar 3, 2022
- 3 min
Kadimastem Receives Grant for a Total Budget of $3.1 million from the Israeli Innovation Authority


- Dec 13, 2021
- 4 min
Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority

- Nov 25, 2021
- 5 min
ILEX Medical to Invest 10 million NIS ($3.2 million)


- Nov 15, 2021
- 1 min
We rang the TASE bell today!

- Oct 25, 2021
- 4 min
Kadimastem Raises NIS 16.1 million ($5 million) In Private Placement


- Oct 12, 2021
- 3 min
Successful Meeting with the FDA (INTERACT) Regarding IsletRx for the Treatment of Diabetes